yet2.com, a technology scouting and intellectual property services firm (Needham, MA), in partnership with NASA Tech Briefs, Clean 15, RadTech, Steinbeis Center for Technology Transfer India, and yet2ventures, has announced that ZetrOZ (Ithaca, NY) is the Top Finalist in its inaugural Step2Change Technology Competition.

alt“Among the submissions we received from around the globe, ZetrOZ’s Mobile Ultrasound Therapy technology stood out with an excellent value proposition addressing the very large global pain therapy market,” said Philip Stern, yet2.com CEO. ZetrOZ was selected as Top Finalist from among four competition finalists. Other finalists included Advanced Brain Monitoring (Carlsbad, CA) for their SmartNap sleep aid, XG Sciences (Lansing, MI) for their xGnP Graphene Nanoplatelets technology, and Evgentech (Atlanta, GA) for their Fast Charging Batteries technology.

All four finalists received presentation slots at yet2.com’s annual Open Innovation Executive Briefing conference in May. With nearly 100 open innovation executives and corporate technology scouts in attendance, presenting at yet2.com’s Executive Briefing XI is extremely valuable market exposure for small companies seeking commercialization partners. All finalists will also receive marketing promotion in yet2.com’s regular e-mail and Web communications. As the Step2Change Top Finalist, ZetrOZ will benefit additionally from four months of expert product commercialization and partner development services from yet2.com, which will engage the firm in direct discussions with target companies to help ZetrOZ take its product to market around the world.

“We couldn’t be more pleased to receive yet2.com’s Top Finalist recognition, as well as to receive their commercialization services,” said Bryant Guffey, CEO of ZetrOZ. “It feels great to have our technology and market strategy validated this way, especially relative to such innovative ideas from other finalists. We anticipate a strong business boost and significant acceleration for our partnering efforts as we benefit from yet2.com’s valuable commercialization expertise and business connections.”

ZetrOZ is revolutionizing the ultrasound industry by introducing proprietary generator technology that is more efficient, more portable, and more economically viable than any ultrasound generator presently available. ZetrOZ’s first product is the world’s smallest ultrasound pain therapy device. This device (currently in clinical trials) addresses the demand for non-pharmaceutical alternatives to current pain treatments in the approximately $50 billion global pain management market.

For more information, visit www.zetroz.com and www.yet2.com.

The U.S. Government does not endorse any commercial product, process, or activity identified on this web site.